June 11, 2020 New Genmab/Abbvie tie-up rings old bells Followers of Nordic Nanovector and Oxford Biomedica, among others, will pay close attention to an early focus of yesterday’s deal.
October 18, 2018 From zero to hero, Endocyte completes a remarkable transformation The US biotech claims an unexpected victory, scoring a $2.1bn takeover by Novartis on the strength of an asset it had bought for just $12m.
September 11, 2015 Upcoming events: Readouts could mean an IPO for Afferent and a licence for Bavarian
